Logo Text

© 2019. DBT, GoI

Powered by

Skip to main content | Screen Reader Access A- A A+


In India, the manufacture, import, research and release of Genetically Engineered Organisms (GEOs), as well as products made by the use of such organisms are governed by The Rules for Manufacture, Use, Import, Export and Storage of Hazardous Micro-Organisms, Genetically Engineered Organisms or Cells, (commonly referred to as “Rules 1989) notified by the Ministry of Environment, Forest and Climate Change (MoEF&CC), on December 5, 1989, under the Environment (Protection) Act 1986.

 The Rules 1989 are broad in scope and covers the area of research as well as large-scale handling of hazardous microorganisms, GE organisms or cells and products thereof. In order to implement the Rules in the entire country, six competent authorities and roles have been notified under the Rules 1989.

Competent Authorities under Rules 1989

Competent Authorities


Recombinant DNA Advisory Committee (RDAC)


Genetic Engineering Appraisal Committee (GEAC)

Regulatory/ Approval

Review Committee on Genetic Manipulation (RCGM)

Institutional Biosafety Committee (IBSC)

State Biotechnology Coordination Committee (SBCC)


District Level Committee (DLC)

Recombinant DNA Advisory Committee (RDAC)

This Committee is set up and functions in the Department of Biotechnology with a role to;

               i.          Review developments in Biotechnology at national and international levels.

             ii.          Shall recommend suitable andappropriate safety regulations for India in recombinant research, use and applications from time to time.

           iii.          Evolve long-term policy for research and development in Recombinant DNA research.


Review Committee on Genetic Manipulation (RCGM)

This Committee shall function from the Department of Biotechnology to monitor the safety related aspect in respect of on-going research projects or activities involving hazardous microorganisms, GE organisms and cells and products thereof. The RCGM shall include representatives of (a) Department of Biotechnology (b) Indian Council of Medical Research (c) Indian Council of Agricultural Research (d) Council of Scientific and Industrial Research (e) other experts in their individual capacity. RCGM may appoint sub groups to assist RCGM on matters related to risk(s) assessment, in reviewing of existing and preparing new guidelines.

RCGM shall bring out Manuals of guidelines specifying procedure for regulatory process with respect to activities involving  GE organisms in research use as well as industrial & environmental applications with a view to ensure human health and environmental safety. All ongoing research projects involving hazardous microorganisms, GE organisms or cells and products thereof shall be reviewed to ensure that adequate precautions and containment conditions are being met.

RCGM shall lay down procedures restricting or prohibiting production, sale, importation and use of such hazardous microorganisms, GE organisms or cells.

Schedule of RCGM Meetings

RCGM Meeting Schedule - 2018

No. of RCGM Meeting


162nd RCGM

09.01.2018 (Tuesday)

163rd RCGM

20.02.2018 (Tuesday)

164th RCGM

03.04.2018 (Tuesday)

165th RCGM

22.05.2018 (Tuesday)

166th RCGM

03.07.2018 (Tuesday)

167th RCGM

21.08.2018 (Tuesday)

168th RCGM

09.10.2018 (Tuesday)

169th RCGM

20.11.2018 (Tuesday)

170th RCGM

08.01.2019 (Tuesday)

 RCGM member list

S. No.




Dr. B. Sesikeran,

Former Director,

National Institute of Nutrition (NIN),

Hyderabad-500 007.



Dr. S. R. Bhat,

Principal Scientist,

National Research Centre on Plant Biotechnology,

New Delhi-110012



Prof. P. Kondaiah,                                         

Chairman, Deptt.of Molecular Reproduction,

Development & Genetics,

Indian Institute of Science, Maleswaram,

Bangalore-560 012.    



Dr.Shailja Hittalmani

Professor & Head,

Deptt.of Genetics and Plant Breeding,

University of Agricultural Sciences,

Bangalore-560 065



Dr. S. J. Rahman
Principal Scientist & Head,

AICRP on Biological Control,

Agricultural Research Institute (ARI),
Prof.JayashankarTelangana State Agri. University,

Hyderabad-500 030



Dr. Vanga Siva Reddy


Biosafety Support Unit (BSU), First Floor,

National Productivity Council,

5-6, Lodhi Road, Institutional Area,

New Delhi – 110003



Dr. S. N. Sudhakara Babu

Principal Scientist (Agronomy)

Directorate of Oilseeds Research,

Hyderabad-500 030



Dr. Natarajan Sakthivel


Deptt. of Biotechnology,

Pondicherry University,

Puducherry-605 014



Dr. Viswanathan Chinnusamy

Principal Scientist & Head,

Division of Plant Physiology,

ICAR-Indian Agricultural Research Institute,

New Delhi-110 012



Dr. Gururaj Katti

Principal Scientist & Head,

Division of Crop Protection,

Indian Institute of Rice Research,

Rajendranagar, Hyderabad–500 030



Dr. S. K. Rath

Principal Scientist,

Division of Toxicology,

CSIR-Central Drug Research Institute,

Lucknow-226 001, Uttar Pradesh



Dr. KulbhushanTikoo

Professor& Head,

Deptt. of Pharmacology & Toxicology,

National Institute of Pharmaceutical Education and Research,

Sec. 67, Mohali-160 062, Punjab



Dr. G. Dhinkar Raj

Project Director,

Translational Research Platform for Veterinary Biological,

2nd Floor, CUL-Building, CAHS, TANUVAS, Madhavaram, Milk Colony,

Chennai-600 051, Tamil Nadu



Dr. A. K. Kondapi


Deptt. of Biotechnology,

School of Life Sciences,

University of Hyderabad,

Hyderabad-500 046, Telangana



Dr. P. V. L. Rao
Scientist ‘G’ & Director,

DRDO-BU Center for Life Sciences,

Bharathiar University Campus,

Coimbatore-641 046, Telangana



Dr. Sanjeev Galande


Indian Institute of Science Education and Research-Pune,

Dr. HomiBhabha Road,

Pune-411 008, Maharashtra



Dr. Debendra K. Sahoo

Senior Principal Scientist,

Biochemical Engineering Research and Process Development Centre,

Institute of Microbial Technology,

Chandigarh-160 036, Punjab



Dr. Amita Aggarwal


Deptt. of Clinical Immunology,

Sanjay Gandhi Postgraduate Institute of Medical Sciences,

Lucknow-226 014, Uttar Pradesh



Dr. Ambikanandan Misra

Professor & Dean,

Faculty of Technology & Engineering,

The Maharaja Sayajirao University of Baroda,

Vadodara-390 001, Gujarat



Dr. Murali Krishna, Ph.D

Nominee (MoEFCC),

Member Secretary, GEAC & Joint Director/ Scientist-D (Biosafety)

2nd Floor, Vayu Block,

Indira ParyavaranBhawan, Jorbagh

Ministry of Environment, Forest & Climate Change, Government of India, New Delhi



Dr. Vijay Kumar


Scientist-‘G’ & Head (BMS)

Indian Council of Medical Research, Head Qtrs.,

Ansari Nagar, Post Box No. 4911,

New Delhi-110 029



Dr. P.K. Chakrabarty,


ADG(PP & B) ICAR Hqrs.,

Department of Agricultural Research & Education,

Indian Council of Agricultural Research (ICAR),

Ministry of Agriculture,

KrishiBhawan, Dr. Rajendra Prasad Road,

New Delhi-110 001



Dr. G. N. Singh,

The Drugs Controller General (India)

Central Drug Standard Control Organization (CDSCO),

Directorate General of Health Services,

FDA Bhawan, Kotla Road,

New Delhi-110 002



Dr. Sanjay Kumar,



CSIR- Institute of Himalayan Bioresource Technology,

Post Box No. 6,

Palampur (H.P) – 176 061



Sh. Ajit M. Sharan


Ministry of AYUSH,

AYUSH Bhawan, B Block,

GPO Complex, INA,

New Delhi-110 023



Prof. Ashutosh Sharma,



Department of Science & Technology,

Technology Bhawan, New Mehrauli Road,

New Delhi-110 016




Nominee (NBPGR),

National Bureau of Plant Genetic Resources,

Pusa Campus, New Delhi-110 012



Dr. S. R. Rao


Department of Biotechnology,

New Delhi-110 003

Member Secretary




Department of Biotechnology,

New Delhi-110 003

Internal Member


Dr. Sanjay Kalia


Department of Biotechnology,

New Delhi-110 003

Internal Member




  1.  As per the Rules for the manufacture, use, import, export & storage of hazardous microorganisms, genetically engineered organisms or cells, 1989 notified under the Environment (Protection)Act, 1986 and as amended from time to time, the Review Committee on Genetic Manipulation (RCGM) shall function in the Department of Biotechnology (DBT) .
  2. RCGM shall monitor the safety related aspects in respect of ongoing recombinant DNA (r-DNA) projects and activities involving Genetically Engineered (GE) organisms/ hazardous microorganisms. All ongoing projects including high risk category and confined field experiments shall be reviewed by RCGM to ensure that adequate precautions and containment conditions are complied with as per the Guidelines and Standard Operating Procedures (SOPs) issued by DBT from time to time.
  3. The RCGM shall lay down procedures restricting or prohibiting production, sale, importation and use of such GE organisms or products thereof for research and applications as mentioned in the schedule of Rules, 1989.
  4. RCGM shall bring out manuals and guidelines specifying procedure for regulatory processes with respect to activities involving GE organisms in research, use and application including industry with a view to ensure safety to human, animal and environment health.
  5. The RCGM would issue the clearance letters/permits for import or exchange of genes, DNA fragments, vectors, plasmids, cosmids, etiologic agents and transgenic organisms or germplasm(s) including transformed calli, seeds, plants and plant parts for research use only. It will also take note of all such commercially available agents which are acquired from commercial sources through Institutional Biosafety Committee (lBSC).
  6. The RCGM shall be the regulatory body for receiving and reviewing the applications to conduct confined field trials (such as event selection trials, Biosafety Research Level I trials (BRL-I), pollen flow studies or any other trial involving GE organisms) and recommend appropriate studies to be conducted for data generation for biosafety assessment as per clause 4, as per the decision of the Genetic Engineering Approval Committee (GEAC) for its authorization.
  7. The RCGM, on case-by-case basis, can authorize applicants to use bioreactors to produce sufficient material/end-products of GE organisms required for conducting pre-clinical studies and other relevant data generation including the use of capacity over and above as specified by Recombinant DNA Safety Guidelines, 1990. It will authorize to produce sufficient quantities of GE organism/plant product(s) for generating safety data in appropriate animals as per National and International Guidelines, as appropriate on case-by-case basis.
  8. The RCGM, if required, call generate, examine or invite the research projects, proposals for capacity building and training courses in biosafety, creation of information systems/data banks in electronic media, websites etc. for financial support and recommend the same to DBT for furthering the cause of generating specific biosafety data related to use of GMOs and strengthening infrastructure facilities & dissemination of information on biosafety rules, regulations and guidelines in the country.
  9. The RCGM may also invite, induct or appoint special experts in their individual capacities on a case by case basis.
  10. The RCGM may constitute subgroups of its members or subcommittees involving experts for specific functions or seek advice on specific matters from other external experts.
  11. The RCGM or its constituted subgroups/subcommittees may visit periodically the experimental sites where r-DNA projects and activities involving GE organisms/ hazardous microorganisms are being pursued to ensure that adequate safety measures have been taken as per the guidelines and compliance of SOPs.
  12. The RCGM shall maintain the classified/confidential business information provided by the applicants as confidential.
  13. The RCGM shall function for a period of three years from the date of notification.
  14. The RCGM shall meet once in a month or as and when required.
  15. The members of RCGM shall be paid TA/DA and honorarium as per the Government of India rules as applicable from time to time.


Institutional Biosafety Committee (IBSC)

This Committee shall be constituted by all institutions handling hazardous microorganisms and/or GE organisms. The Committee will be the nodal point for implementation of the biosafety guidelines and for the interactions within the institution. The Committee shall comprise of the Head of the Institution, Scientists engaged in the recombinant DNA work, a medical doctor and a nominee of the Department of Biotechnology. Institutions handling risk-inherent microorganisms or GE organisms shall prepare, with the assistance of the Institutional Biosafety Committee (IBSC), on-site emergency plan and update from time to time according to the manuals/guidelines of the RCGM and make available copies to the District Level Committee/State Biotechnology Co-ordination Committee and the Genetic Engineering Appraisal Committee.

The constitution, composition, role and functions, information for compliance requirements, processes to be followed while dealing with hazardous microorganisms, GE organisms or cells and product thereof in line with Rules 1989 is described in “Guidelines and Handbook for Institutional Biosafety Committee.  Adherence to the guideline shall be binding for all IBSCs.


Genetic Engineering Appraisal Committee (GEAC)

Genetic Engineering Appraisal Committee (GEAC) [formerly known as Genetic Engineering Approval Committee (GEAC) name changed through Gazette notification, G.S.R No. 613 dated 16th July 2010],  has been established under the Ministry of Environment, Forest and Climate Change (MoEF&CC). The major functions of GEAC as prescribed in the Rules 1989 are:

             i.      To appraise activities involving large scale use of hazardous microorganisms GE organisms or cells in research and industrial production from the environmental angle.

           ii.         To appraise proposals relating to release of GE organisms and products into the environment including experimental field trials.

         iii.         The committee or any persons authorized by it has powers to take punitive action under the Environment (Protection) Act, 1986.

Submission of applications to GEAC, information on current composition, meeting deliberations etc. is available at here.


State Biotechnology Co-ordination Committee (SBCC)

The State Biotechnology Co-ordination Committee (SBCC) is a monitoring committee at State level. It shall have powers:

             i.     To inspect, investigate and to take punitive action in case of violations of statutory provisions through the State Pollution Control Board (SPCB) or the Directorate of Health etc.

           ii.    To review periodically the safety and control measures established at various institutions handling GE organisms.

         iii.      To act as a nodal agency at the State level to assess the damage, if any, due to the release of GE organisms and to take on-site control measures.


District Level Committee (DLC)

There shall be a District Level Biotechnology Committee (DLC) in the districts wherever necessary under the District Collectors to monitor the safety regulations in installations engaged in the use of genetically modified organisms/ hazardous microorganisms and its applications in the environment.

The District Level Committee/or any other person/s authorized in this behalf shall visit the installation engaged in activity involving hazardous microorganisms, GE organisms or cells, and , formulate information chart, find out hazards and  risk(s) associated with each of these installations and coordinate activities with a view to meet any emergency. They shall also prepare an off-site emergency plan. The District Level Committee shall regularly submit its report to the SBCC/ GEAC.